Drug
Dabigatran clinical trials
Also written Pradaxa and BIBR 1048 MS.
How each study uses Dabigatran is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Dabigatran studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Oct 2010 · PRADAXA · NDA 022512 (FDA, Drugs@FDA)
- European Union
- 17 Mar 2008 · Pradaxa · EMEA/H/C/000829 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
147 studies that test it; most in 2013 (11)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 3 |
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 9 |
| 2012 | 8 |
| 2013 | 11 |
| 2014 | 11 |
| 2015 | 7 |
| 2016 | 10 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 6 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 78 · Other 69
Boehringer Ingelheim (66) · Pfizer (3) · The University of Hong Kong (2) · Vanderbilt University Medical Center (2) · Imperial College London (2) · University of Sao Paulo General Hospital (2) · Merck Sharp & Dohme LLC (2) · University of Alberta (2)
Often tested with
Tested in the same studies.
Rivaroxaban (21) · Apixaban (13) · Edoxaban (8) · Warfarin (7) · Midazolam (3) · Rosuvastatin (3) · Enoxaparin (3) · Pantoprazole (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Dabigatran.
- Jun 2027THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)Phase 4 · Imperial College London
Studies
Open first, then newest update. How each study uses Dabigatran is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 147
- Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus BacteremiaRecruitingPhase 4McGill University Health Centre/Research Institute of the McGill University Health CentreNCT06650501Written as Dabigatran
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Dabigatran Etexilate
- Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With CirrhosisNot yet recruitingPhase 2/3Institute of Liver and Biliary Sciences, IndiaNCT06818279Written as Dabigatran
- Dabigatran Versus Rivaroxaban in Cerebral Venous ThrombosisRecruitingPhase 3Kafrelsheikh UniversityNCT06551402Written as Dabigatran Etexilate 150mg
- Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting ConditionsNot yet recruitingPhase 1International Bio serviceNCT06441916Written as Dabigatran Etexilate Capsules 150 mg
- MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke PreventionRecruitingPhase 3University of ZurichNCT03961334Written as Dabigatran
- A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsCompletedPhase 1PfizerNCT07190430Written as Dabigatran Etexilate
- Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial FibrillationCompletedPhase 4Intermountain Health Care, Inc.NCT03061006Written as Dabigatran Etexilate
- Dabigatran for Mitral Stenosis Atrial FibrillationActive, not recruitingPhase 4The University of Hong KongNCT04045093Written as Dabigatran etexilate
- Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy SubjectsCompletedPhase 1The Affiliated Hospital Of Guizhou Medical UniversityNCT06876623Written as dabigatran etexilate mesylate capsules 150mg
- Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).CompletedPhase 4Vanderbilt University Medical CenterNCT03539055Written as Dabigatran Etexilate Oral Capsule
- A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.WithdrawnPhase 1University of Rhode IslandNCT03752294Written as Dabigatran
- The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)Active, not recruitingNot applicableRigshospitalet, DenmarkNCT06449469Written as Dabigatran
- Safety and Tolerability of Dabigatran Etexilate in AdolescentsCompletedPhase 2Boehringer IngelheimNCT00844415Written as dabigatran etexilate
- PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial FibrillationCompletedPhase 3Imperial College LondonNCT03996772Written as Dabigatran
- Dabigatran Versus Apixaban in Cerebral Venous ThrombosisStatus unknownPhase 3Kafrelsheikh UniversityNCT06551415Written as Dabigatran Etexilate 150mg
- A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy ParticipantsCompletedPhase 1Loxo Oncology, Inc.NCT04782076Written as Dabigatran
- PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy ParticipantsCompletedPhase 1PfizerNCT05064800Written as Dabigatran
- A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the BloodCompletedPhase 1Boehringer IngelheimNCT04257032Written as Dabigatran etexilate
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNot applicableAlliance Foundation Trials, LLC.NCT02744092Written as Dabigatran
See all 147 studies that test Dabigatran →
Given beside what is tested · 20 — Dabigatran is usual care or a partner of the new treatment
- Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male ParticipantsRecruitingPhase 1Deciphera Pharmaceuticals, LLCNCT07744802Written as Dabigatran
- Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIRecruitingPhase 4Medical University of GdanskNCT04695106Written as Dabigatran Etexilate
- Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy VolunteersCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT06945276Written as Dabigatran
- A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy AdultsWithdrawnPhase 1BayerNCT07515339Written as Dabigatran etexilate
- A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy SubjectsCompletedPhase 1Lumosa Therapeutics Co., Ltd.NCT04809818Written as Dabigatran
- A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the BloodCompletedPhase 1Boehringer IngelheimNCT06504862Written as Dabigatran-etexilate
- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial FibrillationActive, not recruitingPhase 4Herlev and Gentofte HospitalNCT03129490Written as Dabigatran Etexilate Oral Capsule
- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)Active, not recruitingPhase 4Herlev and Gentofte HospitalNCT03129555Written as Dabigatran Etexilate Oral Capsule
- Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and CamlipixantCompletedPhase 1Bellus Health Inc. - a GSK companyNCT05959447Written as Dabigatran etexilate
- A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02945020Written as Dabigatran etexilate mesylate
- A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04208061Written as Dabigatran Etexilate
- A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy AdultsCompletedPhase 1PfizerNCT05673889Written as Dabigatran etexilate
- A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy ParticipantsCompletedPhase 1BayerNCT06329895Written as Dabigatran etexilate
- Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female VolunteersCompletedPhase 1AstraZenecaNCT05438303Written as Dabigatran Etexilate
- Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy ParticipantsCompletedPhase 1PfizerNCT03742336Written as Dabigatran
- Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran EtexilateCompletedPhase 1Boehringer IngelheimNCT01688830Written as Dabigatran
- Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02028780Written as dabigatran
- BIBR 953 ZW in Healthy Elderly SubjectsCompletedPhase 1Boehringer IngelheimNCT02173730Written as BIBR 1048 MS
- Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02171559Written as Dabigatran etexilate capsules
- Bioavailability of BIBR 1048 MS Single Doses With or Without Pantoprazole in Healthy SubjectsCompletedPhase 1Boehringer IngelheimNCT02170805Written as BIBR 1048 MS capsule formulation A
As the comparator · 6 — what is tested is compared with Dabigatran
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical TherapyCompletedPhase 4Charite University, Berlin, GermanyNCT03463317Written as Dabigatran
- A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed ConditionStatus unknownPhase 1Hong Kong WD Pharmaceutical Co., LimitedNCT04592822Written as Pradaxa®
- Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male VolunteersStatus unknownPhase 1Huons Co., Ltd.NCT03495739Written as Dabigatran Etexilate Mesylate 150 MG Oral Capsule
- Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02710630Written as Dabigatran etexilate capsule
- The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation PatientsStatus unknownPhase 4The First Affiliated Hospital with Nanjing Medical UniversityNCT02646267Written as dabigatran etexilate
- Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02171442Written as BIBR 1048 Oral Solution
Codes
What other systems call Dabigatran · ClinicalTrials.gg INT006619
- MeSH (NLM) D000069604DabigatranConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) I0VM4M70GCDABIGATRANConfirmed FDA, NLM, Wikidata
- RxNorm 1546356Confirmed FDA, Wikidata
- Wikidata Q419345dabigatranConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73224DabigatranOne source FDA
- DrugBank DB14726One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069604 | Dabigatran | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | I0VM4M70GC | DABIGATRAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1546356 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419345 | dabigatran | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73224 | Dabigatran | One source FDA |
| DrugBank | DB14726 | — | One source Wikidata |
Also registered as dabigatran etexilate (UNII 2E18WX195X · RxNorm 1037042) and dabigatran etexilate mesylate (UNII SC7NUW5IIT · RxNorm 1037041).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.